01 July 2019 | News
Genetic Testing Augmented by AI and Facial Analysis
Image credit- advanceweb.com
US based FDNA, a leader in artificial intelligence and precision medicine, has announced the launch of Face2Gene LABS as part of a broader collaboration with PerkinElmer, Inc., a global leader committed to innovating for a healthier world.
Together, they will offer genomic services paired with next-generation phenotyping (NGP) technologies for more efficient and accurate diagnoses.
By combining FDNA’s artificial intelligence-based technologies and services with PerkinElmer’s longstanding diagnostics expertise and state-of-the-art clinical genomics program, Face2Gene LABS will give clinicians access to: